Reductions in resistance exercise-induced hyperglycaemic episodes are associated with circulating interleukin-6 in Type 1 diabetes

Diabetic Medicine

Volumn 31, Issue 8, 2014, Pages 1009-1013

  Turner, D ^a   Luzio, S ^a,b   Kilduff, L P ^a   Gray, B J ^a   Dunseath, G ^a   Bain, S C ^a,b   Campbell, M D ^c   West, D J ^c   Bracken, R M ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b SINGLETON HOSPITAL   (United Kingdom)

^c NORTHUMBRIA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INTERLEUKIN 6; ANTIDIABETIC AGENT; GLARGINE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; LONG ACTING INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXTRACELLULAR FLUID; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PH; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESISTANCE TRAINING; ANALYSIS; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 1; DIABETIC DIET; METABOLISM; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SKELETAL MUSCLE; TIME; UPREGULATION;

ADULT; BLOOD GLUCOSE; COHORT STUDIES; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 1; DIABETIC DIET; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN, LONG-ACTING; INTERLEUKIN-6; MALE; MUSCLE, SKELETAL; RESISTANCE TRAINING; RETROSPECTIVE STUDIES; TIME FACTORS; UP-REGULATION;

EID: 84904395906     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12462     Document Type: Article

References (19)

1. Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1. Nat Med 2011; 17: 1481-1489.
2. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, Bakker PJ et al. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 1995; 268: E813-819.
3. Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 2006; 55: 2688-2697.
4. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 2002; 16: 1335-1347.
5. Toft AD, Falahati A, Steensberg A. Source and kinetics of interleukin-6 in humans during exercise demonstrated by a minimally invasive model. Eur J Appl Physiol 2011; 111: 1351-1359.
6. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009; 94: 3171-3182.
7. Jenni S, Wueest S, Konrad D, Stettler C. Response of interleukin-6 during euglycaemic and hyperglycaemic exercise in patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 2010; 89: e27-29.
8. Rosa JS, Flores RL, Oliver SR, Pontello AM, Zaldivar FP, Galassetti PR. Resting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 days. J Appl Physiol 2010; 108: 334-342.
9. Galassetti PR, Iwanaga K, Pontello AM, Zaldivar FP, Flores RL, Larson JK. Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes. Am J Physiol Endocrinol Metab 2006; 290: E833-839.
10. Rosa JS, Oliver SR, Flores RL, Ngo J, Milne GL, Zaldivar FP, et al. Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes. Pediatr Diabetes 2011; 12: 464-472.
11. Phillips MD, Mitchell JB, Currie-Elolf LM, Yellott RC, Hubing KA. Influence of commonly employed resistance exercise protocols on circulating IL-6 and indices of insulin sensitivity. J Strength Cond Res 2010; 24: 1091-1101.
12. Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev 2006; 12: 6-33.
13. Turner D, Luzio S, Gray BJ, Dunseath G, Rees ED, Kilduff LP et al. Impact of single and multiple sets of resistance exercise in type 1 diabetes. Scand J Med Sci Sports 2014; doi: 10.1111/sms.12202 [Epub ahead of print].
14. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription, 6th ed. Philadelphia (PA): Lippincott Williams, Wilkins, 2000.
15. American Diabetes Association. Physical Activity/Exercise and. Diabetes. 2004; 27(Suppl. 1): S58-S62.
16. van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 2003; 88: 3005-3010.
17. Gannon MC, Nuttall FQ, Westphal SA, Neil BJ, Seaquist ER. Effects of dose of ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects. Diabetes Care 1989; 12: 544-552.
18. Cerretelli P, Samaja M. Acid-base balance at exercise in normoxia and in chronic hypoxia. Revisiting the "lactate paradox". Eur J Appl Physiol 2003; 90: 431-448.
19. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B et al. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 2001; 537: 633-639.